Academic Journal

Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin

التفاصيل البيبلوغرافية
العنوان: Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin
المؤلفون: Giovannetti, E., Zucali, P.A., Assaraf, Y.G., Leon, L.G., Smid, K, Alecci, C., Giancola, F., Destro, A., Gianoncelli, L., Lorenzi, E., Roncalli, M., Santoro, A., Peters, G.J.
المصدر: Giovannetti , E , Zucali , P A , Assaraf , Y G , Leon , L G , Smid , K , Alecci , C , Giancola , F , Destro , A , Gianoncelli , L , Lorenzi , E , Roncalli , M , Santoro , A & Peters , G J 2011 , ' Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin ' , British Journal of Cancer , vol. 105 , no. 10 , pp. 1542-1553 . https://doi.org/10.1038/bjc.2011.400
سنة النشر: 2011
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: unknown
DOI: 10.1038/bjc.2011.400
الاتاحة: https://research.vumc.nl/en/publications/63ddadc1-7af3-4879-b61e-9074f3e1d091
https://doi.org/10.1038/bjc.2011.400
https://research.vumc.nl/ws/files/877294/282702.pdf
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.65969397
قاعدة البيانات: BASE